Диссертация (1154706), страница 13
Текст из файла (страница 13)
- 1996. - № 6 (71).- C. 543–551.44. Cavasi A., Cavasi E. Relationship between NT-proBNP and Cardio-RenalDysfunction in Patients with Advanced Liver Cirrhosis // J Gastrointestin Liver Dis. 2014. - № 1 (23). - C. 51–56.45. Cazzaniga, M., Salerno, F., Pagnozzi, G., Dionigi, E., Visentin, S., Cirello I..100Diastolic dysfunction is associated with poor survival in cirrhotic patients withtransjugular intrahepatic portosystemic shunt // gut. - 2007.
- № 56. - C. 869–875.46. Ceolotto G., Papparella .I, Sticca A., Bova S., Cavalli M., Cargnelli G.,Semplicini A., Gatta A. An abnormal gene expression of the beta-adrenergic systemcontributes to the pathogenesis of cardiomyopathy in cirrhotic rats. // Hepatology.2008.- № 48. - C. 1913–1924.47. Choi J.-O. Longitudinal 2D strain at rest predicts the presence of left main andthree vessel coronary artery disease in patients without regional wall motionabnormality // European Journal of Echocardiography. - 2009. - № 5 (10).
- C. 695–701.48. Cohen E.J., Klatsky A.L. Alcohol use and supraventricular arrhythmia. // Am JCardiol. - 1988.- № 62.- C. 971–3.49. Coss E., Watt K.D., Pedersen R., Dierkhising R., Heimbach J.K. Predictors ofcardiovascular events after liver transplantation; A role for pretransplant serumtroponin levels. // Liver Transpl. - 2011.
- (17). - C. 23–31.50. Cox K., Puddey I.B., Morton A.R., Vandongen R. Controlled comparison ofeffects of exercise and alcohol on blood pressure and serum high density lipoproteincholesterol in sedentary males. // Clin Exp Pharmacol Physiol. - 1990. - (7). - C.
251–5.51. Day, P.C., James, F.W.O., Butler, J.T., and Campbell R. Q–T prolongation andsudden cardiac death in patients with alcoholic liver disease. // Lancet. - 1993. - №341. - C. 1423–1428.52. Dec G.W., Kondo N., Farrell M.L., Dienstag J. Cardiovascular complicationsfollowing liver transplantation. // Clin Transplant. - 1995.- (9).- C. 463–471.53. Edwards B.S.
Coexistent pulmonary and portal hypertension: Morphologic andclinical features // Journal of the American College of Cardiology. - 1987. - № 6 (10).- C. 1233–1238.54. Elliott C.G. Worldwide Physician Education and Training in PulmonaryHypertension // Chest.- 2010. - № 6 (137). - C. 85S–94S.10155.
Epstein M. Relationship of increased plasma atrial natriuretic factor and renalsodium handling during immersion-induced central hypervolemia in normal humans.// Journal of Clinical Investigation. - 1987. - № 3 (79).- C. 738–745.56. Ettinger P.O., Wu C.F., De La Cruz C., Weisse A.B., Ahmed S. Arrhythmias andthe “holiday heart”: alcoholassociated cardiac rhythm disorders. // Am Heart J.1978.
- № 95. - C. 555–62.57. Fede G., Privitera G., Tomaselli T., Spadaro L. P. Cardiovascular dysfunction inpatients with liver cirrhosis // Ann Gastroenterol.- 2015. - (28). - C. 31–40.58. Fernandez-Muñoz D, Caramelo C, Santos JC, Blanchart A H. Systemic andsplanchnic hemodynamic disturbances in conscious rats with experimental livercirrhosis without ascites.
// Am J Physiol.- 1985. - № 249. - C. 316–20.59. Fields, N.G., Yuan, B.X., Leenen F.H. Sodium-induced cardiac hypertrophy.Cardiac sympathetic activity versus volume load // Circ Res. - 1991.- № 68.- C.745–755.60. Finucci, G., Desideri, A., Sacerdoti, D., Bolognesi, M., Merkel, C., Angeli P. Leftventricular diastolic function in liver cirrhosis // Scand J Gastroenterol. - 1996. - №31. - C. 279–284.61.
Florence Wong, Samuel Siu. Brain natriuretic peptide: is it a predictor ofcardiomyopathy in cirrhosis? // Clinical Science.- 2001. - № 101. - C. 621–628.62. Friberg J., Jensen G. Alcohol consumption and risk of atrial fibrillation in menand women.
The Copenhagen City Heart Study. // Circulation. - 2005. - № 112. - C.1736–42.63. Frith J. N.Autonomic dysfunction in chronic liver disease. // Liver Int. - 2009. № 29. - C. 483–489.64. Galasko G. What is the normal range for N-terminal pro-brain natriuretic peptide?How well does this normal range screen for cardiovascular disease? // EuropeanHeart Journal.- 2005.- № 21 (26). - C. 2269–2276.65.
Galie N. Corrigendum to: «Guidelines for the diagnosis and treatment ofpulmonary hypertension» [European Heart Journal (2009) 30, 2493-2537]. The Task102Force for the Diagnosis and Treatment of Pulmonary Hypertension of the EuropeanSociety of Cardiology (ESC) and // European Heart Journal. - 2011. - № 8 (32). - C.926–926.66. Gaskari S.A., Liu H., Moezi L., Baik S.K. Role of endocannabinoids in thepathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats // Br J Pharmacol. 2005. - № 146.- C. 315–23.67.
Genovesi, S., Prata Pizzala, D.M., Pozzi, M., Ratti, L., Milanese, M., Pieruzzi F.QT interval prolongation and decreased heart rate variability in cirrhotic patients:relevance of hepatic venous pressure gradient and serum calcium. // ClinSci. - 2008.№ 116. - C. 851–859.68. Gerbes A.L., Remien J., Jüngst D., Sauerbruch T. Evidence for down-regulationof beta-2-adrenoceptors in cirrhotic patients with severe ascites.
// Lancet. - 1986. № 1. C. 1409–1411.69. Gould L, Zahir M, Shariff M. Cardiac hemodynamics in alcoholic heart disease. //Ann Intern Med.- 1969. - № 71. - C. 543–554.70. Goyal S.K. Assessment of the Model for End-stage Liver Disease (MELD) Scorein Predicting Prognosis of Patients with Alcoholic Hepatitis // Journal of Clinical andExperimental Hepatology. - 2014.- № 1 (4). - C. 19–24.71. Gupta D. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepaticportal venous obstruction // The American Journal of Gastroenterology. - 2001.- №12 (96).
- C. 3395–3399.72. Hadengue A., Lebrec D., Benhamou J.-P. Pulmonary Arterial Hypertension inPatients with Portal Hypertension Tokyo: Springer Japan, 1991. 401–411 с.73. Hall E.M., Olson A.Y. D.F.E. Portal cirrhosis: clinical and pathological review of782 cases from 16,600 necropsies. // Am J Pathol.
- 1953. - № 29. - C. 993–1027.74. Hendrickse M.T, Thuluvath P.J. Natural history of autonomic neuropathy inchronic liver disease. // Lancet. - 1992. - № 339. - C. 1462–1464.75. Hendrickse M.T. Peripheral and cardiovascular autonomic impairment in chronicliver disease: prevalence and relation to hepatic function. // Hepatology. - 1992.- №10316. C. 177–183.76.
Henriksen, J.H., Bendtsen, F., Hansen, E.F., Møller S. Acute non-selective betaadrenergic blockade reduces prolonged frequency-adjusted Q–T interval (QTc) inpatients with cirrhosis // Hepatology. - 2004. - № 40. - C. 239–246.77. Henriksen, J.H., Fuglsang, S., Bendtsen, F., Christensen, E., and Møller S.Dyssynchronous electrical and mechanical systole in patients with cirrhosis //Hepatology.- 2002. - № 36. - C. 513–520.78. Hervé P.
Increased plasma serotonin in primary pulmonary hypertension // TheAmerican Journal of Medicine. - 1995. - № 3 (99). - C. 249–254.79. Hervé P. Pulmonary vascular disorders in portal hypertension // EuropeanRespiratory Journal. - 1998. - № 5 (11). - C.
1153–1166.80. Huonker, M., Schumacher, Y.O., Ochs, A., Sorichter, S., Keul, J., Rôssle M.Cardiac function and haemodynamics in alcoholic cirrhosis and effects of thetransjugular intrahepatic portosystemic stent shunt // gut. - 1999. - № 44. - C. 743–748.81. Henriksen J.H, Gøtze J. P., Fuglsang S. Increased circulating pro-brainnatriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients withcirrhosis: relation to cardiovascular dysfunction and severity of disease // Gut. - 2003.- № 52. - C.
1511–1517.82. Ruf J.C. Wine and polyphenols related to platelet aggregation andatherothrombosis. // DrugExp. AndClin. Res.- 1999. - № 2-3 (25). - C. 125–31.83. Jaue D.N., Ma Z. Cardiac muscarinic receptor function in rats with cirrhoticcardiomyopathy. // Hepatology. - 1977. - № 25. - C. 1361–1365.84. Kahn D., Esquivel C.O., Madrigal-Torres M., Todo S.
An Analysis of the Causesof Death After Pediatric Liver Transplantation. // Transplant Proc. - 1988. - № 20.C. 613–615.85. Kakimoto H., Imai Y., Kawata S., Inada M., Ito T. Altered lipid composition anddifferential changes in activities of membrane-bound enzymes of erythrocytes inhepatic cirrhosis. // Metabolism. - 1995.- № 44. - C. 825–832.10486. Kamath P. Hepatic Localization of Endothelin-1 in Patients With IdiopathicPortal Hypertension and Cirrhosis of the Liver // Liver Transplantation. - 2000.- № 5(6). - C.
596–602.87. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD) //Hepatology. - 2007. - № 3 (45).- C. 797–805.88. Kawut S.M. Clinical risk factors for portopulmonary hypertension // Hepatology.- 2008. - № 1 (48).- C. 196–203.89. Kazankov K., Holland-Fischer P., Andersen N.H. Resting myocardial dysfunctionin cirrhosis quantified by tissue Doppler imaging. // Liver Int.- 2011.- № 31. - C.534–540.90.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
